Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors

New agreements with major airports and airlines reflect growing demand for Bruker’s trace detection technologies, with a focus on Europe ETTLINGEN, Germany -- Bruker Corporation (Nasdaq: BRKR) today announced the signing of multiple new contracts and framework agreements for its explosives and chemical trace detection solutions, accessories, consumables, and service offerings. Finalized throughout 2025, these agreements [...]

Revvity Launches Innovative Reagent Technology to Accelerate Development of Next-Generation Targeted Therapeutics

Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY), today announced the launch of pHSense™ reagents, a powerful technology designed to advance internalization studies in drug discovery. pHSense reagents are designed for high-throughput, plate-based workflows and intended for researchers studying G protein-coupled receptors [...]

CRAIC Technologies Introduces Smart Merge: Seamless Spectral Integration Across UV-VIS-NIR Ranges

San Dimas, CA — CRAIC Technologies, a global leader in advanced microspectroscopy solutions, is proud to announce the release of Smart Merge, a groundbreaking software feature designed to enhance multi-spectral data integration across UV-VIS-NIR and extended NIR ranges. Built into CRAIC’s powerful LambdaFire™ software suite, Smart Merge represents a major leap forward in spectral accuracy and data flexibility [...]

LabConnect Deploys Sapio LIMS Across Global Operations

New LIMSConnect system streamlines workflows and supports scalable innovation BALTIMORE -- Sapio Sciences, the science-awareTM lab informatics platform, today announced the full deployment of Sapio LIMS at LabConnect. Internally branded as LIMSConnect, the system now serves as the unified Laboratory Information Management System (LIMS) across LabConnect’s global network of over 30 locations across six continents. LabConnect, a leading [...]

Pleno Inc. Announces First Commercial Agreement with Slopes Bio, Inc.

Slopes Bio to Utilize Pleno’s transformative RAPTOR instruments and consumables for processing more than 100,000 samples annually SAN DIEGO -- Pleno Inc., an early-stage biotechnology company developing innovative multi-omic solutions, and Slopes Bio, Inc., an innovative high-complexity accredited laboratory, today announced a comprehensive commercial agreement in biological target detection and personalized health. The agreement marks the [...]

Ganymede Launches Scientific AI Agent Platform to Accelerate Process Development, R&D, and Manufacturing

PALO ALTO, Calif. -- Ganymede, the scientific data cloud, today announced the launch of its Scientific AI Agent Platform — the first secure, deterministic AI agents purpose-built for science, engineering, and hard tech industries. This marks a significant expansion of Ganymede’s platform with a particular focus on process development, introducing a new category of task-oriented [...]

Bio-Techne Announces Exosome Diagnostics Divestiture

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement where Mdxhealth SA will acquire its Exosome Diagnostics Inc. business, including the ExoDx Prostate (EPI) test, CLIA-certified clinical laboratory and related assets. Bio-Techne will retain access to the proprietary exosome-based technology for ongoing kit development in its precision diagnostics growth pillar. "Mdxhealth is the ideal [...]

Trailhead Biosystems Expands iPSC-Derived Portfolio with TrailBio® Hematopoietic Progenitor Cells

BEACHWOOD, Ohio -- Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced pluripotent stem cells (iPSCs), announces the commercial release of TrailBio® Hematopoietic Progenitor Cells. These progenitor cells are derived from a single, well-characterized iPSC line using Trailhead's proprietary High-Dimensional Design-of-Experiments (HD-DoE®) platform, providing researchers with a consistent, scalable, [...]

Mission Bio Secures Equity Financing to Accelerate Single-Cell Tri-omics Platform Expansion

Investment to Drive Commercial Growth, Advance Single-Cell Tri-omics Capabilities and Clinical Applications Across Cancer Company Adds to Leadership Team, with Matthew H. Cato Joining as CCO SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the successful completion of equity financing led by Ally Bridge Group. [...]

Promega, Aobious Resolve Patent Infringement Lawsuit

Consent Judgment confirms Aobious infringed Promega patents covering luciferase substrate compounds Settlement includes permanent injunction against Aobious and monetary payments to Promega Promega reaffirms commitment to providing high-quality reagents to scientists through authorized distribution channels MADISON, Wis.--Promega Corporation and Aobious Inc. have entered into a settlement agreement to resolve a patent infringement lawsuit related to [...]

Access IBO on Knowledge Center